View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Oseltamivir Phosphate

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Alert: Two Overdoses of Tamiflu in Pediatric Patients in Pennsylvania

2009 NOV 16 ... eliminate the risks are also provided in the Advisory." Keywords: Drugs, Oseltamivir Phosphate, Pediatrics, Pharmaceuticals, Regulatory Actions, Tamiflu, Therapy, Treatment, ...

Subject: Pediatrics

Price: $3.00

Community Pharmacists Report Supply Shortages, Insurance Red Tape in Growing Fight against H1N1 Flu

2009 NOV 16 ... Reform, Pharmaceutical, Pediatrics, Insurance, Drugs, H1N1 Virus, Infectious Disease, Oseltamivir Phosphate, Pediatrics, Pharmaceuticals, Swine Flu, Swine Influenza, Tamiflu, Therapy, Treatment, ...

Subject: National Community Pharmacists Association

Price: $3.00

FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet

2009 NOV 1 ... by the FDA for treatment and prophylaxis of the 2009 H1N1 influenza virus are Tamiflu (oseltamivir phosphate) and Relenza (zanamivir). Tamiflu and Relenza, in addition to their ...

Subject: Influenza

Price: $3.00

FDA, FTC Issue Joint Warning Letter to Web Site Offering Fraudulent H1N1 Flu Supplements

2009 NOV 2 ... by the FDA for treatment and prophylaxis of the 2009 H1N1 influenza virus - Tamiflu (oseltamivir phosphate) and Relenza (zanamivir). Tamiflu and Relenza, in addition to their approved labeling, ...

Subject: Influenza

Price: $3.00

Gilead Sciences Announces Record Third Quarter 2009 Financial Results

2009 NOV 2 ... the third quarter of 2008. This increase was driven primarily by higher Tamiflu® (oseltamivir phosphate) royalties from F. Hoffmann-La Roche Ltd of $113.5 million in the third quarter of 2009, ...

Subject: Gilead Sciences, Inc.

Price: $3.00

Grady Health System Using LiveProcess to Manage H1N1 Surge

2009 NOV 2 ... Medical Supplies, Software, Technology, Antiviral, CDC, Drugs, Emergency Preparedness, Oseltamivir Phosphate, Pharmaceuticals, Tamiflu, Treatment, U.S. Centers for Disease Control and Prevention, ...

Subject: LiveProcess

Price: $3.00

HHS Orders Intravenous Antiviral Flu Medication to Help Patients Hospitalized with 2009 H1N1

2009 NOV 16 ... H1N1 Virus, Immunization, Infectious Disease, Neuraminidase, Oseltamivir, Oseltamivir Phosphate, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Regulatory Actions, ...

Subject: U.S. Department of Health and Human Services

Price: $3.00

Hovione's TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza

2009 SEP 21 ... Trial Research, Drugs, Enzyme Research, Flu, Influenza, Neuraminidase, Oseltamivir, Oseltamivir Phosphate, Pandemics, Patents Actions, Pediatrics, Pharmaceuticals, Tamiflu, Therapy, Treatment, ...

Subject: Influenza

Price: $3.00

In Vitro Study of Adamas Pharmaceuticals' Triple Combination Antiviral Drug Therapy Shows Activity Against Drug-Resistant Influenza Viruses

2009 SEP 28 ... to be administered adjunctively with a neuraminidase inhibitor such as Tamiflu (oseltamivir phosphate, Roche). In this study, using a scientifically accepted in vitro infection model, ...

Subject: Influenza

Price: $3.00

Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009

2009 NOV 9 ... HIV, Human Immunodeficiency Virus Viral Infection, Immunization, Neuraminidase, Oseltamivir Phosphate, Pharmaceuticals, Relenza, Tamiflu, Therapy, Treatment, Viral Inhibition, Viral Therapy, ...

Subject: Immunization

Price: $3.00

Mortuary Response Solutions Develops Portable Mass Fatality Remains Storage Systems

2009 SEP 28 ... Diseases, Public, Engineered, Technology, Drugs, Flu, Immunization, Influenza, Oseltamivir Phosphate, Pharmaceuticals, Tamiflu, Therapy, Treatment, Vaccination, Mortuary Response Solutions. ...

Subject: Mortuary Response Solutions

Price: $3.00

New anti-infectives study findings reported from T. Ogihara and co-authors

2009 SEP 21 ... Influenza, Influenza Virus, Metabolism, Neuraminidase, Oncology, Oseltamivir, Oseltamivir Phosphate, Pharmaceuticals, Psychiatry, Tamiflu, Therapy, Treatment, Viral Research, Virology. ...

Subject: Anti-Infectives

Price: $3.00

NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009

2009 SEP 28 ... Disease, Influenza, Influenza Virus, Marketing and Licensing Agreements, NexBio Inc., Oseltamivir Phosphate, Paramyxoviridae, Paramyxovirus, Pharmaceuticals, Pre-Trials Research, Pulmonology, ...

Subject: Influenza

Price: $3.00

SDI Reports: Antiviral Prescriptions Increase 36% in 1 Week

2009 NOV 2 ... Investing, Investment, Antiviral, Biotechnology Business, Biotechnology Company, Drugs, Oseltamivir Phosphate, Pharmaceuticals, Relenza, Tamiflu, Treatment, Viral Inhibition, Viral Therapy, ...

Subject: SDI

Price: $3.00

SDI Reports: Antiviral Prescriptions Increase 73% in Past Two Weeks

2009 NOV 9 ... Investing, Investment, Antiviral, Biotechnology Business, Biotechnology Company, Drugs, Oseltamivir Phosphate, Pandemics, Pharmaceuticals, Tamiflu, Treatment, Viral Inhibition, Viral Therapy, ...

Subject: SDI

Price: $3.00

Study data from T. Arai and co-authors update knowledge of anti-infectives

2009 NOV 16 ... "Oseltamivir phosphate (Tamiflu ®) is an anti-influenza drug approved in many countries. Recently, in ...

Subject: Anti-Infectives

Price: $3.00

Triple-combo drug shows promise against antiviral-resistant H1N1, UAB researcher says

2009 NOV 16 ... Drug Resistance, Drug Therapy, Drugs, H1N1 Virus, Infectious Diseases, Oseltamivir, Oseltamivir Phosphate, Pediatric, Pharmaceuticals, Ribavirin, Swine Flu, Swine Influenza, Symmetrel, Tamiflu, ...

Subject: Virology

Price: $3.00

Two New Studies Report Increased Survival Rates in Tamiflu(R)-Treated Patients with Avian Flu (H5N1) and Severe Seasonal Flu

2009 SEP 28 ... two new observational studies concluded that influenza patients treated with Tamiflu (oseltamivir phosphate) had significantly higher survival rates than untreated patients. The studies, examining ...

Subject: Influenza

Price: $3.00

Walmart Pharmacists Prepare and Offer Tamiflu(R) for Oral Suspension for Children and Elderly at More Than 4,000 Locations

2009 NOV 1 ... the U.S. Food and Drug Administration (FDA) to treat and prevent influenza. Tamiflu=AE (oseltamivir phosphate) is one of two FDA-approved influenza antiviral drugs that is recommended by CDC for use ...

Subject: Pharmaceuticals

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx